All visitors are required to wear masks.

For COVID-19 safety, all visitors to ChristianaCare facilities and services are required to wear masks. This includes visitors who are vaccinated. Please read our visitor guidelines before arrival.

Masks required at outpatient locations; visitors and support persons limited

All visitors at outpatient locations must be masked in alignment with the masking guidelines on our visitation policy page here. Patients at ChristianaCare’s outpatient services are advised to come to their appointments alone unless a support person is absolutely needed. If a support person is needed, such as a parent, guardian or spokesperson, we highly encourage that the support person be vaccinated. Outpatient practices are not requiring vaccination or a negative COVID test for visitors at this time.

All hospital visitors required to be vaccinated or have a negative COVID-19 test.

  • Inpatients in our Christiana, Wilmington and Union hospitals may have one visitor daily between 10 a.m. and 8 p.m. The visitor must be 16 or older.
  • Patients having outpatient surgery may have one support person accompany them. Support persons must be 16 or older.
  • All visitors and surgical support people must show proof of vaccination OR a negative COVID-19 test within the prior 72 hours.

Before visiting, click here for more details about visitation.

Visit or for local vaccination and testing sites.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

Meet Our OPACT Advocates


Lisa Cerullo Gilroy

Debilitated by a massive tumor, Lisa went to the doctor and learned that she had stage IV nonHodgkin’s lymphoma. She participated in a clinical trial which resulted in an earlier-than-expected recovery. Lisa supports women worrying about the impact of treatment on fertility and what to expect in a clinical trial.

Leila Hamroun

Leila is a breast cancer survivor – and the mother of three children. Leila got regular check-ups, never smoked and had no family history of breast cancer. Yet, she developed stage II breast cancer. Leila gives back by participating in a trial and supporting other clinical trial participants.

Danny Fisher

Danny was diagnosed with prostate cancer in 2014 and after doing a lot of research he opted to participate in a hormone suppression clinical trial. He also underwent five weeks of radiation therapy and had radioactive seeds implanted. Danny takes pride in educating others with prostate cancer and supports participation in clinical trials.

Lisa Lankford

Lisa was diagnosed with stage IIB Hodgkin’s Lymphoma in 2014, after finding an enlarged lymph node under her arm. Her cancer required intensive chemotherapy and radiation therapy and Lisa joined a clinical trial that looked at the effect of exercise on her level of fatigue during treatment. She helps others cope with cancer by sharing her experiences with cancer and clinical trials.

Linda Larrimore

Linda was diagnosed with stage IV colon cancer in 2011 and has participated in several clinical trials. She is a passionate advocate for colon cancer screening and clinical trial participation. She states “without the trials and the volunteers participating in them, how will we find a cure?”

John Mantakounis

John was diagnosed with stage IV lung cancer in 2010. After obtaining a second opinion, he decided to enroll in a clinical trial offered by ChristianaCare. John now shares his lifechanging experience with others through clinical trial advocacy.

Bob Pietschmann

Bob is a survivor of a rare head and neck cancer; he was diagnosed in 2009. Found in just one lymph node, this cancer required both chemotherapy and radiation therapy. After benefiting from a randomized clinical trial, Bob gladly helps others go through the clinical trial process.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Suite 2200, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.